The Patent Finder

Chiron Behring GmbH & Co.

Also on record
Records under this name other than patents Chiron Behring GmbH & Co. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Chiron Behring GmbH & Co.

PatentTitleStatus Expires Confidence
US 10,329,536Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture
Formerly held
Term ended
Term ended Mar 7, 2023 · High confidence
Term endedTerm ended Mar 7, 2023High confidence
US 6,656,720Animal Cells and Processes for the Replication of Influenza Viruses
Formerly held
Term ended
Ended no later than Apr 17, 2021 · Low confidence
Term endedEnded no later than Apr 17, 2021Low confidence
US 7,772,386Identification of specific differentially expressed antigens
Formerly held
Term ended
Term ended Jan 28, 2020 · From the USPTO record
Term endedTerm ended Jan 28, 2020From the USPTO record
US 6,300,102Immunogenic hybrid protein OprF-Oprl derived from Pseudomonas aeruginosa membrane proteins
Term ended
Term ended Mar 10, 2019 · From the USPTO record
Term endedTerm ended Mar 10, 2019From the USPTO record
US 6,455,298Animal cells and processes for the replication of influenza viruses
Formerly held
Term ended
Term ended Sep 29, 2018 · From the USPTO record
Term endedTerm ended Sep 29, 2018From the USPTO record
US 4,271,147Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same
Term ended
Term ended no later than Jun 2, 2001 · Low confidence
Term endedTerm ended no later than Jun 2, 2001Low confidence
US 4,275,165Process for isolating hepatitis A-virus
Term ended
Term ended no later than Jun 23, 2001 · Low confidence
Term endedTerm ended no later than Jun 23, 2001Low confidence
US 4,891,226Pharmaceutical which can be administered nasally, a process for its preparation, and its use
Term ended
Term ended no later than Jan 2, 2010 · Low confidence
Term endedTerm ended no later than Jan 2, 2010Low confidence
US 5,194,587Malaria-specific DNA sequences, expression products thereof, and the use thereof
Term ended
Term ended no later than Mar 16, 2013 · Low confidence
Term endedTerm ended no later than Mar 16, 2013Low confidence
US 5,393,523Plasmodium falciparum vaccine comprising a recombinant histidine-rich protein-HRP-II
Term ended
Term ended no later than Feb 28, 2015 · Low confidence
Term endedTerm ended no later than Feb 28, 2015Low confidence
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited